NASDAQ: MYGN Shareholder Notice: Investigation of Potential Wrongdoing at Myriad Genetics, Inc.
An investigation was announced for investors in shares of Myriad Genetics, Inc. (NASDAQ: MYGN) concerning potential breaches of fiduciary duties by certain directors and officers of Myriad Genetics, Inc..
View full press release